Abbott Unveils Cutting-Edge Healthcare Innovations for Indian Market

Abbott Laboratories is making significant strides in the Indian healthcare sector with the introduction of advanced medical technologies. The company recently launched the AVEIR VR leadless pacemaker, a groundbreaking device for treating slow heart rhythms12. This minimally invasive pacemaker is implanted directly into the heart, reducing complications associated with traditional pacemakers. Abbott is also exploring biosimilars for chronic conditions and has launched seven such treatments in India1. The company's focus on digital innovation and connected care devices aims to improve patient outcomes and increase access to healthcare solutions across the country1.

 

Source: Fortune India